Novartis' $3 billion MorphoSys boondoggle $NVS $MOR

It's the lead item in this week's newsletter. (With a meme!) I also dug into the $ANVS Alzheimer's data spin.

Adam's Biotech Scorecard is free to STAT + subscribers. Sign up!

Web version here: statnews.com/2024/05/02/nov…

$PDSB just hired a new COO who came from $AVXL.

Oh boy...

Novartis $NVS extends radiopharma plans with $1 billion acquisition statnews.com/2024/05/02/nov… via Allison DeAngelis

BridgeBio $BBIO spins out oncology company as it focuses on heart drug statnews.com/2024/05/02/bri… via Elaine Chen

Moderna $MRNA ends collaboration with CRISPR company Metagenomi $MGX, parts ways with gene editing chief statnews.com/2024/05/01/mod… via Jason Mast

Today, a 2-year STAT investigation by Katherine Eban and team.

Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show statnews.com/2024/05/01/bra…

As part of its Living Brain Project, Mt. Sinai physicians removed small pieces of brain…

When is the $CTMX PIPE?

Eli Lilly $LLY raises earnings guidance as Zepbound sales beat expectations statnews.com/2024/04/30/eli… via Elaine Chen

Activist investor Alex Denner, Bioverativ shareholder reach tentative settlement in insider trading case statnews.com/2024/04/29/ale…

Denner had been accused of using his position as a Bioverativ board member to make nearly $50 million from insider trading in connection with the…

It's amazing -- and quite sad -- to see Alzheimer's disease attract the worst in biotech. $ANVS $BIVI $SAVA

Edited: $AVXL, too!

Patients exploited. Investors bamboozled.

Sorry, sorry, I was away from this platform and didn't see the $ANVS bullshit data dump.

A big fail and so much spin, as expected.

Ono Pharmaceuticals acquiring $DCPH for $2.4 billion.

investors.deciphera.com/news-releases/…

Another Enhertu win for $DSNKY $AZN

daiichisankyo.us/press-releases…

Enhertu is rewriting the rules of breast cancer diagnosis and treatment.

Sunday story from me. Important enough not to wait for Monday. $MOR $NVS

New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition statnews.com/2024/04/28/mor…

#COYS

Attention early-career journalists! STAT is extending applications for the Sharon Begley Science Reporting Fellowship by one week. The deadline is now Friday, May 3. KSJ at MIT trib.al/L3F92qD

$VINC is what happens when you shop a wall-crossed PIPE with bad data, and get turned down by funds.

This week's Biotech Scorecard newsletter:

- Profiting from ‘legal’ insider trading isn’t always easy. A look at 2024 PIPE performance.
- Benitec Biopharma $BNTC: A gene therapy for OPMD improves swallowing. Single patient, so far. More data coming.
- More watercooler chatter…

Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread statnews.com/2024/04/25/h5n… via Megan Molteni